摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[2-(2-(3-acetyl-5-amino-1phenylpyrazol-4-yl)-7-methoxy-1,3,4-thiadiazolo[3,2-a]indol-9-yl)ethyl]acetamide | 1257651-02-7

中文名称
——
中文别名
——
英文名称
N-[2-(2-(3-acetyl-5-amino-1phenylpyrazol-4-yl)-7-methoxy-1,3,4-thiadiazolo[3,2-a]indol-9-yl)ethyl]acetamide
英文别名
N-[2-[2-(3-acetyl-5-amino-1-phenylpyrazol-4-yl)-6-methoxy-[1,3,4]thiadiazolo[3,2-a]indol-4-yl]ethyl]acetamide
N-[2-(2-(3-acetyl-5-amino-1phenylpyrazol-4-yl)-7-methoxy-1,3,4-thiadiazolo[3,2-a]indol-9-yl)ethyl]acetamide化学式
CAS
1257651-02-7
化学式
C25H24N6O3S
mdl
——
分子量
488.57
InChiKey
XRTYIICIJCLGEK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    35
  • 可旋转键数:
    7
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    145
  • 氢给体数:
    2
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    1-氯-1-(2-苯基亚肼基)乙酮N-[2-(2-cyanomethyl-6-methoxy-1,3,4-thiadiazolo[3,2-a]indol-4-yl)ethyl]acetamidesodium 作用下, 以 乙醇 为溶剂, 以70%的产率得到N-[2-(2-(3-acetyl-5-amino-1phenylpyrazol-4-yl)-7-methoxy-1,3,4-thiadiazolo[3,2-a]indol-9-yl)ethyl]acetamide
    参考文献:
    名称:
    Potent neuroprotective role of novel melatonin derivatives for management of central neuropathy induced by acrylamide in rats
    摘要:
    Acrylamide (ACR) has been shown to be a neurotoxic agent for both laboratory animals and human. The present study aimed at synthesizing new functionalized melatonin derivatives bearing promising heterocyclic moiety that could be expected to have protective effect against ACR-induced neurotoxicity in adult female rats. The novel melatonin derivatives 4, 6, 7 and 11 were synthesized and their chemical structures were confirmed by studying their analytical and spectral data. The administration of ACR [i.p., 50 mg kg(-1) body weight (b. wt.)] alone resulted in significant increase in brain malondialdehyde level (MDA) and lactate dehydrogenase (LDH) activity whereas it caused significant decrease in brain monoamines levels and antioxidant enzymes activity. Treatment with melatonin derivatives 4, 6, 7 and 11 (i.p., 50 mg kg(-1) b. wt) prior to ACR produced significant decrease in brain MDA level and LDH activity with concomitant significant increase in brain monoamines and antioxidant enzymes activity. It could be concluded that the new synthesized melatonin derivatives exhibited promising protective activity against ACR-induced neurotoxicity. (C) 2010 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2010.09.017
点击查看最新优质反应信息